REQUEST PRICE

Fields with * are required
Premium Phosphosite-Specific 7TM Antibodies
Novel Tools for Your GPCR Research
Select Your Country of Delivery below

Immuno-Grade Dopamine Receptor 2 Antibodies

Close filters
No results were found for the filter!
NEW
Immunohistochemical identification of Dopamine Receptor 2 in human neuroendocrine tumor.
D2 (IHC-grade), Dopamine Receptor 2 Antibody
The D2 receptor antibody is directed against the third intracellular loop of mouse, rat and human D2 dopamine receptor. It detects both the long and short form of D2. It can be used to detect total D2 receptors in Western blots...
$ 350.00

The D2 receptor is a pharmacological target for drugs widely used to treat symptoms for disorders associated with dopaminergic dysfunctions, including Parkinson’s disease and schizophrenia. D2 is expressed on neuronal cell bodies and fibers in distinct regions of the central nervous system including caudate-putamen and nucleus accumbens. In the periphery, D2 is found in the endocrine system including anterior pituitary and enterochromaffine cells throughout the gut. D2 is also abundant in pituitary adenomas including prolactinomas and other neuroendocrine tumors.

The D2 receptor is a pharmacological target for drugs widely used to treat symptoms for disorders associated with dopaminergic dysfunctions, including Parkinson’s disease and schizophrenia. D2 is... read more »
Close window
Immuno-Grade Dopamine Receptor 2 Antibodies

The D2 receptor is a pharmacological target for drugs widely used to treat symptoms for disorders associated with dopaminergic dysfunctions, including Parkinson’s disease and schizophrenia. D2 is expressed on neuronal cell bodies and fibers in distinct regions of the central nervous system including caudate-putamen and nucleus accumbens. In the periphery, D2 is found in the endocrine system including anterior pituitary and enterochromaffine cells throughout the gut. D2 is also abundant in pituitary adenomas including prolactinomas and other neuroendocrine tumors.

Recently viewed